BIOATLA INC (BCAB) Stock Analyst Ratings
NASDAQ:BCAB - Nasdaq - US09077B1044 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 82% to BCAB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 9.69. This target is 2274.42% above the current price.
BCAB was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about BCAB.
In the previous month the buy percentage consensus was at a similar level.
BCAB was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-13 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-09-16 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-05-23 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-28 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-03-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-12-05 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-11-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-09-25 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-08-02 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-08-02 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-08-02 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-08-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-15 | JMP Securities | Reiterate | Outperform -> Outperform |
| 2023-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-12 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-04-17 | EF Hutton | Maintains | Buy |
| 2023-04-03 | JP Morgan | Maintains | Overweight |
| 2023-03-28 | BTIG | Maintains | Buy |
| 2023-03-27 | JMP Securities | Maintains | Outperform |
| 2023-03-24 | EF Hutton | Reiterate | Buy |
| 2023-03-24 | Credit Suisse | Reiterate | Neutral |
| 2023-03-24 | HC Wainwright & Co. | Maintains | Buy |
| 2023-01-05 | EF Hutton | Initiate | Buy |
| 2022-11-04 | Credit Suisse | Maintains | Neutral |
| 2022-09-15 | JMP Securities | Initiate | Market Outperform |
| 2022-08-10 | Credit Suisse | Maintains | Neutral |
| 2022-08-10 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-05 | Credit Suisse | Downgrade | Outperform -> Neutral |